Food Allergy Diagnosis Treatment Market Report 2024 (Global Edition)

Factors Affecting the Food Allergy Treatment Market

The high prevalence of food allergy instances among children is lifting the market growth.

Food allergy in children is a major health concern, and it is reportedly rising worldwide. Parents often over-diagnose the allergy situation, resulting in the exclusion of some important food items from the consumption plate. Food allergy may result in some serious conditions sometimes and this makes parents anxious, and immediately look for treatment options. There is currently no direct cure to food allergy however available treatment options aim to reduce the occurrence of symptoms. The worldwide prevalence of food allergy is estimated to be around 4% of children however the cases reported were observed to be varying because of lack of awareness about the food allergy and their reaction patterns. 
(Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134150/)

Furthermore, 40% of children in the UK have been diagnosed with an allergy. The most common allergies found in children are food allergies, eczema, asthma, and hay fever. 
(Source: https://www.allergyuk.org/about-allergy/allergy-in-childhood/)

Food allergy cases in the United States are also rising. It is estimated to affect around 8% of children in the United States which means every 1 in 13 children is allergic to at least one food substance. Talking about the symptoms, the publication states that the symptoms and severity of allergic reactions to food may vary from person to person, however, more than 40% of children with food allergies in the United States have been treated in the emergency department.
(Source: https://www.cdc.gov/healthyschools/foodallergies/index.htm#:~:text=Food%20allergies%20are%20a%20growing,children%20in%20the%20United%20States).

The rising number of food allergy cases among children is becoming a concerning factor for parents, leading them to search for effective treatment options. Thus, the rising food allergic cases among children is driving the parents’ perspective towards various treatment options and the fact that parents are ready to pay even high prices to reduce the sufferance of their children is directly driving the growth of the food allergy treatment market.

High costs related to food allergy treatment somewhat restrict the growth of the market.

The diagnosis and treatment cost related to food allergy can be expensive depending on the type of food allergy and the intensity. The total cost may vary because most of the diagnostic tools used for testing and diagnosing food allergies are performed using trial and error methods to conclude whether the particular food product or substance is the cause of the immune system reaction. For instance, the Food Allergy Test kit from YorkTest, available as an at-home blood test kit, is worth $132.
(Source: https://www.yorktest.com/us/blog/allergy-test-cost/#:~:text=Now%2C%20when%20it%20comes%20to,how%20many%20allergens%20are%20tested.)

Whereas, the average cost for food allergy testing in the Primary Care Centre of Clear Lake, experienced medical health professionals, may range from $100 to $500. The cost of food allergy diagnosis mainly depends on the criticality and number of tests that need to be conducted. A basic skin prick test, which can screen for multiple allergens at once, might cost around $250 whereas more comprehensive blood tests, which can determine specific antibodies to certain foods, can cost ranging from $200 to $1000. 
(Source: https://primarycareofclearlake.com/food-allergy-testing-cost)

The cost spent on healthcare costs related to food allergies and disorders is estimated to be $25B every year., This high cost related to the diagnosis and treatment of allergy reactions is becoming one of the main factors that compels people to think before approaching treatment options. 

The introduction of innovative food allergen testing tools & techniques by conducting thorough research and development can widen the scope of the market and its growth.

Food allergy, triggered by a particular food substance or allergens can be mild and sometimes may create serious health concern issues as well. The healthcare sector is currently in a position to offer an effective diagnosis and treatment options however, the scope is limited as the food allergy case and symptoms differ from the person-to-person depending on their immune system. This makes it a bit difficult for the technology and healthcare sector to recognize and treat them. To overcome this and to be more advanced in diagnosing and providing treatment; companies and government institutions have started investing in research and development activities.     

Treatment options like immunotherapy are already revolutionizing allergy management. Effective and accurate testing is critical to identify particular food allergens and sensitivities to enable tailored treatment plans for individuals to safely navigate their dietary needs and improve their quality of life. The existing techniques for food allergy treatment include routine diagnostic tests like oral food challenges, skin-prick tests, and allergen-specific IgE detection are already prevailing in the market. However, new test techniques like basophil activation test, mast cell activation test, and bead-based epitope assay, all focused on specificity and multiplexing capabilities, are also in the development stages. Many companies have introduced as well as invested to improve food allergic conditions.

The allergy research campaign is not just limited to experimental approaches, the deployment of Artificial intelligence and Machine Learning is also revolutionizing the field by aiding in the understanding of disease mechanisms. 
(Source: https://www.news-medical.net/health/The-Future-of-Food-Allergy-Management-New-Technologies-and-Treatments.aspx)

For instance, AllerGenis, Inc. a commercial-stage company providing the next generation of food allergy testing using cutting-edge systems biology and data analytics, announced an online crowdfunding campaign on StartEngine. Regulation Crowdfunding allows everyone to invest in startup companies, regardless of their net worth or income level to enable more individuals with food allergies deeper clarity into their allergy. 
(Source: https://www.allergenis.com/news-articles-1/allergenis-to-present-at-biotech-showcase-9xmkc)

Thus, the latest developments in food allergy immunotherapy are promising, with innovative approaches like chimeric antigen receptor cell therapy bringing a new scope for the healthcare sector industries. 

How did the COVID–19 Impact the Food Allergy Treatment Market?

The coronavirus disease (COVID-19), an infectious disease caused by the severe acute respiratory syndrome coronavirus broke out in the year 2019. This had impacted the whole world within such a short time that the World Health Organization had to declare it a global health emergency. The virus initially spread as a fatal disease killing a large number of people across the world, compelling countries and governments to impose lockdowns to control the infection spreading further. The lockdown imposition disrupted the movement and operation of many industries as the distribution and supply movement was directly and heavily impacted. This inflexibility in the movement disrupted the healthcare industry as well. Doctor-patient direct and person-to-person connectivity suddenly stopped due to lockdown situations because of which medications and treatments were delayed.

However, healthcare providers introduced virtual treatment options to continue the treatment process which helped the sector to recover slowly, and now with the latest technology and virtual flexibility, people started feeling comfortable with virtual treatments.

Recent developments

•    16th February 2024: the United States Food and Drug Administration approved Roche, Novartis’ Xolair, the first medicine introduced to reduce allergic reactions that can occur with accidental exposure to certain foods. 
(Source: https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-help-reduce-allergic-reactions-multiple-foods-after-accidental) 
•    24th January 2024: Kaléo, a privately-held pharmaceutical company, signed a partnership with Brittany Mahomes, co-owner of the Kansas City Current soccer team and mom of two young children with food allergies, to raise awareness of how to recognize and respond to a life-threatening food allergy reaction in infants and toddler. 
(Source: https://ians.in/pr-wire-detail/brittany-mahomes-helps-raise-awareness-of-food-allergies-in-young-children-24-01-2024) 
•    8th January 2024: Inimmune Corporation and Intrommune Therapeutics announce a collaboration to advance a revolutionary rapid, long-acting oral mucosal allergy immunotherapy for the treatment of peanut allergy.
(Source: https://intrommune.com/2024/01/08/2024-1-8-inimmune-corporation-and-intrommune-therapeutics-announce-a-collaboration-to-advance-a-revolutionary-rapid-long-acting-oral-mucosal-allergy-immunotherapy-for-the-treatment-of-peanut-allergy/) 
•    August 2023: Ukko, has developed a safer treatment for people with peanut allergies to help them develop a tolerance to the seed.
(Source: https://nocamels.com/2023/08/ai-led-peanut-allergy-treatment-offers-hope-for-severely-affected/#:~:text=Ukko%2C%20on%20the%20other%20hand,system%20to%20build%20up%20tolerance.&text=The%20startup%20collected%20hundreds%20of,to%20%E2%80%9Cmap%E2%80%9D%20the%20intolerance.) 
•    29th November 2023: Camallergy, a pioneer in developing oral immunotherapy treatments for food allergies, and OnDosis, a leader in intelligent dosing of oral solid medicines, announced their strategic collaboration to revolutionize Food Allergy treatment.
(Source: https://www.camallergy.com/camallergy-ondosis-partnership) 
•    13th September: FARE (Food Allergy Research & Education), the nation’s leading non-profit organization engaged in food allergy advocacy and largest private funder of food allergy research, and CVS Pharmacy®, part of the Pharmacy and Consumer Wellness division of CVS Health®, one of America’s most trusted health care solutions brands, have again joined forces to promote food allergy inclusivity during major holidays and observances throughout the year.
(Source: https://www.foodallergy.org/media-room/fare-and-cvs-pharmacy-partner-teal-pumpkin-project-bringing-safe-and-inclusive-offerings) 
•    19th October 2021: COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles to treat immune disorders, announced that the first patient has been dosed in the company’s first-in-human proof-of-concept trial of CNP-201 to treat Peanut allergy.
(Source: https://www.prnewswire.com/news-releases/cour-pharmaceuticals-announces-first-in-human-dosing-in-proof-of-concept-trial-of-cnp-201-to-treat-peanut-allergy-301403393.html) 

With the help of the above study about the Food Allergy Treatment Market, it can be concluded that the market for Food Allergy Treatment worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.

Frequently Asked Questions (FAQs)